Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis

por Woopen, Christina, Schleußner, Katharina, Akgün, Katja, Ziemssen, Tjalf
Publicado 2021

Case report: Variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses

por Woopen, Christina, Konofalska, Urszula, Akgün, Katja, Ziemssen, Tjalf
Publicado 2022

Timing of SARS-CoV-2 Vaccination Matters in People With Multiple Sclerosis on Pulsed Anti-CD20 Treatment

por Woopen, Christina, Dunsche, Marie, Haase, Rocco, Raposo, Catarina, Pedotti, Rosetta, Akgün, Katja, Ziemssen, Tjalf
Publicado 2022

NVX-CoV2373-induced T- and B-cellular immunity in immunosuppressed people with multiple sclerosis that failed to respond to mRNA and viral vector SARS-CoV-2 vaccines

por Mueller-Enz, Magdalena, Woopen, Christina, Katoul Al Rahbani, Georges, Haase, Rocco, Dunsche, Marie, Ziemssen, Tjalf, Akgün, Katja
Publicado 2023

Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy

por Woopen, Christina, Dunsche, Marie, Al Rahbani, Georges Katoul, Dillenseger, Anja, Atta, Yassin, Haase, Rocco, Raposo, Catarina, Pedotti, Rosetta, Ziemssen, Tjalf, Akgün, Katja
Publicado 2023

Differential effects of selective versus unselective sphingosine 1-phosphate receptor modulators on T- and B-cell response to SARS-CoV-2 vaccination

por Proschmann, Undine, Mueller-Enz, Magdalena, Woopen, Christina, Katoul Al Rahbani, Georges, Haase, Rocco, Dillenseger, Anja, Dunsche, Marie, Atta, Yassin, Ziemssen, Tjalf, Akgün, Katja
Publicado 2023